Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma ropivacaine levels with conventional vs extrafascial interscalene block
jRCT1030250642Recruiting
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in rotator cuff tear, adhesive capsulitis (AC) and shoulder joint disorder (2 arms), sponsored by none. Primary endpoints: Maximum plasma concentration of ropivacaine (Cmax) and Time to maximum plasma concentration (Tmax). Started Jan 2026; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
rotator cuff tearadhesive capsulitis (AC)shoulder joint disorder
Beyond the preview
Go deeper on jRCT1030250642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030250642.